Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Macular Edema Incidence/Severity Reduction With Nevanac
Authors not listed
Alcon Research · 2009
Abstract
The purpose of this study is to evaluate NEVANAC in patients with diabetic retinopathy who developed macular edema (ME) within 90 days following cataract surgery.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-15 MST
Cite this
APA
Anonymous. (2009). Macular Edema Incidence/Severity Reduction With Nevanac. <em>Alcon Research</em>. https://clinicaltrials.gov/study/NCT00939276
Vancouver
Anonymous. Macular Edema Incidence/Severity Reduction With Nevanac. Alcon Research. 2009.
BibTeX
@misc{anon2009Macula,
title = {Macular Edema Incidence/Severity Reduction With Nevanac},
author = {Anonymous},
journal = {Alcon Research},
year = {2009},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Alcon Research 2008
Open access · US-GOV
A Clinical Safety and Efficacy Comparison of NEVANAC 0.1% to Vehicle Following Cataract Surgery in Diabetic Retinopathy Patients
Carmen Clapp 2017
Open access · US-GOV
Clinical Trial to Evaluate the Safety and Efficacy of Levosulpiride to Improve Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema.
Justis Ehlers 2014
Open access · US-GOV
Safety and Efficacy of Intravitreal Ranibizumab for Diabetic Macular Edema Previously Treated With Intravitreal Bevacizumab: A Randomized Dual Arm Comparative Dosing Trial
CoMentis 2007
Open access · US-GOV
Phase 2 Study of the Safety and Bioactivity of Topical Ocular Mecamylamine for the Treatment of Diabetic Macular Edema (DME)
Isfahan Ophthalmology Research Center
Open access · US-GOV
Intravitreal Bevacizumab for Diabetic Macular Edema
Johns Hopkins University 2012
Open access · US-GOV